Investor. Investment Committee Chair. Founder. Author.
Maryann Selfe is the Founder, Managing Partner and Chief Investment Officer of Calabar Capital, author of The Billion Dollar Blindspot and originator of The Precision Premium investment thesis.
She received the Women in Wealth Management Switzerland Award in 2025 and serves as a Trustee and Investment Committee Member of the EIRIS Foundation.
Her institutional investment career spans more than two decades across public and private markets. At Credit Suisse (later UBS), her responsibilities included investing client capital, building investment portfolios and structuring complex cross-border investment solutions, with investment-risk oversight across more than $100 billion in client assets.
She served on the executive management team of a Swiss private bank and chaired the Swiss Investment Committee at Banque Internationale à Luxembourg Suisse, with leadership responsibilities spanning investment strategy, governance and capital allocation. Across her career, she has held formal investment veto rights, reviewed more than 1,000 managers and participated in more than 90 investment allocations.
That experience informs her approach today: rigorous manager assessment, disciplined portfolio construction and the judgement to challenge an investment before committing capital.
A diagnosis of uterine fibroids prompted a deeper examination of women's healthcare, revealing gaps in care, unmet needs and an overlooked investment opportunity.
Turning conviction into investment.
Through Calabar Capital, she brings institutional investment discipline to women's health and healthcare technology, combining specialist venture funds with direct co-investments.
Her original thesis, The Precision Premium, identifies the potential value created when a more precise understanding of biology, clinical needs and lived experience leads to better healthcare and durable businesses. Women's health is a leading edge of this broader healthcare transition.
Bringing the opportunity into focus.
Her book, The Billion Dollar Blindspot: Why Women's Health Is the Investment Opportunity of Our Time, and continuing research bring women's health into the investment conversation.
Her work has featured in Institutional Investor, FT Professional Wealth Management, Fast Company and WealthBriefing. She contributes to international investment and healthcare forums through keynotes, executive briefings and commentary.
As Founder and President of FemmeHealth Alliance, she convenes investors, specialist fund managers, healthcare leaders, founders, clinicians and researchers advancing women's health.
Leadership & recognition
- Founder, Managing Partner & CIO, Calabar Capital
- Former Executive Management Team Member, Swiss Private Bank
- Former Chair, Swiss Investment Committee, Banque Internationale à Luxembourg Suisse
- Trustee & Investment Committee Member, EIRIS Foundation
- Founder & President, FemmeHealth Alliance
- Women in Wealth Management Switzerland Award, 2025
Professional qualifications
- FCCA — Fellow of the Association of Chartered Certified Accountants
- MBA — Cardiff University
- Private Markets Programme — Oxford Saïd Business School
Advisory & executive briefings
Working with boards, investment committees and leadership teams on the investment implications of women's health and healthcare innovation.